NCT06901505 Phase 3 Completed
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis Study sponsor: Akebia Therapeutics
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2026-08-12 Actual
Enrollment · participants 353 Actual
Source updated 2026-09-04 Last update listed in the registry record
Version history
Changes to this trial Last 12 months Posted 2026-09-04 · 3 fields changed
Completion date type Recorded edit − Previous value Estimated
Primary completion date Recorded edit + Updated value 2026-08-12
Recruitment status Recorded edit − Previous value Active not recruiting
Check registry source Posted 2026-02-23 · 4 fields changed
Participant count type Recorded edit − Previous value Estimated
Enrollment · participant count Recorded edit − Previous value count: 350; type: ESTIMATED
+ Updated value count: 353; type: ACTUAL
Primary completion date Recorded edit
Recruitment status Recorded edit − Previous value Recruiting
+ Updated value Active not recruiting
Check registry source This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology
Trial